Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
- 3rd side (hint)
Can involve visual
auditory olfactory or gustatory regions of the brain. Autonomic symptoms – epigastric sensations sweating flushing pupillary dilation |
Partial seizure
|
|
|
Begin in childhood and cease by age 20
|
Absence (petit mal)
|
|
|
Marked changes in tone
attacks may have a more gradual onset and termination than in typical absence commonly occur in patients with multiple seizure types accompanied by mental retardation or by developmental delay |
Atypical absence
|
|
|
Consist of single or multiple myoclonic jerks
|
Myoclonic seizures
|
|
|
Characterized by sudden loss of consciousness
patient becomes rigid and falls to the ground respiration arrested (1 minute) followed by clonic phase in which there is a jerking of the body musculature (2-3 minutes) |
Tonic-clonic (grand mal)
|
|
|
Immediately after seizure
patient may either recover consciousness drift into sleep have further convulsions without recovery of consciousness between attacks |
Status epilepticus
|
|
|
External plantar responses (positive Babinski) seen when?
|
In post ictal period
lateralized or focal signs |
|
|
MRI indicated for patients with
|
Focal neurologic symptoms
especially in new onset of seizures after the age of 20 (may indicate neoplasm) |
|
|
Conditions that must be considered in the differential diagnosis of partial seizures.
|
Transient ischemic attack
rage attack panic attack |
|
|
Conditions that must be considered in the differential diagnosis of generalized seizures.
|
Syncope
cardiac dysrhythmia brainstem ischemia pseudoseizures |
|
|
What to remember when changing seizure drugs
|
The dose increased depending on tolerance
the first drug is gradually withdrawn |
|
|
In most cases
seizures of a single type can be controlled with |
A single anticonvulsant drug
|
|
|
Treatment with two drugs may further reduce seizure frequency or severity
but usually at the cost of |
Greater toxicity
|
|
|
Must be monitored to provide a reference point for the maximum tolerated dose
|
Trough levels
|
|
|
Discontinuation of medication only when
|
Seizure free for 2 years
|
|
|
Only when patients are refractory to drug therapy
|
Surgical intervention
|
|
|
Treatment with anticonvulsive drugs is not required for
|
Alcohol withdrawal seizures
|
|
|
Benzodiazepines are effective and safe for preventing seizures of what type?
|
Further alcohol induced seizures
|
|
|
Cause is uncertain
sometimes inherited in an autosomal dominant manner may begin at any age and is enhanced by emotional stress |
Benign essential tremor
|
|
|
Treatment often unnecessary
but when it is required: propanolol primidone then ........ alprazolam clozapine topiramate gabapentin mirtazapine then ........ consider antiepileptic agents. |
Benign essential tremor
(familial tremor) |
|
|
MPTP for recreational purposes
gene mutations exposure to certain toxins severe CO poisoning neuroleptic drugs progressive space occupying lesion (Use acronym mtpt) |
Causes of parkinsonism
|
MPTP definition
a neurotoxin C 12 H 15 N destroys dopamine-producing neurons of the substantia nigra causes symptoms (as tremors and rigidity) similar to those of Parkinson's disease [ 1- m ethyl-4- p henyl-1,2,3,6- t etrahydro p yridine ] : |
|
Tremor conspicuous at rest
rigidity bradykinesia postural instability mild decline in intellectual function characteristically flexed posture seen in many patients less swinging of arms while walking |
Parkinson's
|
|
|
Dopamine depletion due to degeneration of the dopaminergic nigrostriatal system leading to an imbalance of dopamine and acetylcholine
|
Parkinson’s
|
|
|
Post encephalatic
typical and reversible are all non-idiopathic forms of what disease? |
Parkinson’s
|
|
|
In Parkinson’s
repetitive tapping over the bridge of the nose produces a sustained blink response called what? |
Myerson sign
|
|
|
T or F: Parkinson’s disease cause muscle weakness and alteration in dtrs
|
False
|
|
|
Old age
depression Wilson disease Huntington disease Shy-Drager syndrome Creutzfeldt-Jacob disease and cortical-basal ganglionic degeneration is the Ddx for what disease? |
Parkinson’s
|
|
|
Most commonly used medications for parkinsonism.
|
Levodopa and carbidopa
|
|
|
Unstable
CAG nucleotide repeat onset usually between 30 and 50 earliest mental changes are behavioral Irritability, Moodines, Antisocial Psychiatric Disturbance, Dementia |
Huntington's disease.
|
|
|
More common in Western Europeans
who live in temperate zones. No populations are at higher risk for ??This Dz?? when living between latitudes 40N and 40S |
MS
|
|
|
Genetic susceptibility
(association with specific HLA antigens) focal areas of demyelination w reactive gliosis found scattered in the white matter of brain spinal cord & optic nerves axonal damage also occurs |
Multiple sclerosis
(MS) |
|
|
Examination often reveals a residual deficit.
Optic Atrophy Nystagmus Dysarthria; Pyramidal, Cerebellar & Sensory DEFICITS |
MS
|
|
|
What are the two different presentations in the course of MS?
|
Relapsing <-----> remitting
primary -----> progressive secondary -----> progressive |
|
|
Weakness
numbness tingling unsteadiness of limb spastic paraparesis retrobulbar neuritis diplopia disequilibrium or sphincter disturbance (urinary urgency or hesitancy) common initial presentation of ? What Dz ? |
MS
|
|
|
Imaging for MS
|
MRI
|
|
|
May be mild lymphocytosis
or slightly increased protein IgG in CSF but dx is NEVER based on lab findings |
MS
|
|
|
Rule for definite diagnosis of MS
|
Two Lesions
in Space or Time |
|
|
Name that MS drug?
Recovery from acute relapses may be hastened. Rx daily x1 week after which Rx tapered over the following 2-3 wks. Long term Tx provides no benefits & does not prevent further relapses |
Corticosteroids
|
|
|
Name that MS drug?
Used in patients w relapsing-remitting or secondary progressive Dz can be used indefinitely reduces frequency of exacerbations. |
Beta-interferon
|
|
|
Name that M.S. Rx
Used in Pts w relapsing-remitting or secondary progressive Dz. Reduces frequency of exacerbations administered subQ |
Glatiramer
|
|